Advertisement

Related Videos

Sarah Yim, MD, on Clinical Development of Biosimilars: Lessons for Interventional Pharmacoeconomics

The Interventional Pharmacoeconomic Toolbox Panel Discussion

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

Peter Clark, MA, MD, FRCP: A Payer Perspective

Advertisement

Advertisement




Jun
19
Today In Oncology
Overall Survival With EBRT in Hepatocellular Carcinoma
HCC TACE Plus STRIDE With or Without Lenvatinib
St Jude Redesignation Marks Collaboration With WHO Toward Improved Pediatric Cancer Outcomes Globally
FDA Warns of Ongoing Breast Biopsy Needle Shortage
New ACSM Expert Consensus Statement: Exercise in Children and Adolescents With Cancer
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo